Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023		34,219
Balance, value at Dec. 31, 2023	$ 914,998	$ 342	$ 332,621	$ 738,511	$ (2,114)	$ (154,362)
Beginning balance (in shares) at Dec. 31, 2023						3,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	24,946			24,946
Foreign currency translation adjustment	(964)				(964)
Stock compensation expense	2,639		2,639
Net settlement of restricted stock units (in shares)		47				19
Net settlement of restricted stock units	(1,434)	$ 1	(1)			$ (1,434)
Ending balance (in shares) at Mar. 31, 2024		34,266
Balance, value at Mar. 31, 2024	$ 940,185	$ 343	335,259	763,457	(3,078)	$ (155,796)
Ending balance (in shares) at Mar. 31, 2024						3,797
Beginning balance (in shares) at Dec. 31, 2024	34,313	34,313
Balance, value at Dec. 31, 2024	$ 1,048,034	$ 343	343,583	875,851	(5,326)	$ (166,417)
Beginning balance (in shares) at Dec. 31, 2024	3,960					3,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 21,119			21,119
Foreign currency translation adjustment	49				49
Stock compensation expense	3,071		3,071
Net settlement of restricted stock units (in shares)		88				36
Net settlement of restricted stock units	(2,369)	$ 1	(1)			$ (2,369)
Excise tax on repurchase of common stock	(566)					$ (566)
Common stock repurchased under stock repurchase program (in shares)						915
Common stock repurchased under stock repurchase program	$ (60,000)					$ (60,000)
Ending balance (in shares) at Mar. 31, 2025	34,313	34,401
Balance, value at Mar. 31, 2025	$ 1,009,338	$ 344	$ 346,653	$ 896,970	$ (5,277)	$ (229,352)
Ending balance (in shares) at Mar. 31, 2025	4,911					4,911